N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT
Israel
268475
Filed on 2008-05-30
268475
Filed on 2008-05-30
Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium
The Netherlands
07751073.3
Filed on 2007-02-15
07751073.3
Filed on 2007-02-15
Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium
Ireland
07751073.3
Filed on 2007-02-15
07751073.3
Filed on 2007-02-15
Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium
United Kingdom
07751073.3
Filed on 2007-02-15
07751073.3
Filed on 2007-02-15
Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium
France
07751073.3
Filed on 2007-02-15
07751073.3
Filed on 2007-02-15
Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium
Germany
07751073.3
Filed on 2007-02-15
07751073.3
Filed on 2007-02-15
Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium
Switzerland
07751073.3
Filed on 2007-02-15
07751073.3
Filed on 2007-02-15
N-ACETYL MANNOSAMMINE AS A THERAPEUTIC AGENT
US Patent 10,953,026
Filed on 2019-05-20
Filed on 2019-05-20
Targeted Integration Into The Albumin (Alb) Locus As A Treatment For Hereditary Methylmalonic Acidemia (MMA) Caused By Methylmalonyl-coA Mutase (MUT) Deficiency
Patent Cooperation Treaty
PCT/US2018/058307
Filed on 2018-10-30
PCT/US2018/058307
Filed on 2018-10-30